J.D. Eaton

467 total citations
7 papers, 351 citations indexed

About

J.D. Eaton is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, J.D. Eaton has authored 7 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Hematology and 3 papers in Immunology. Recurrent topics in J.D. Eaton's work include Hematopoietic Stem Cell Transplantation (3 papers), Immunotherapy and Immune Responses (3 papers) and RNA Interference and Gene Delivery (2 papers). J.D. Eaton is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Immunotherapy and Immune Responses (3 papers) and RNA Interference and Gene Delivery (2 papers). J.D. Eaton collaborates with scholars based in United Kingdom and Austria. J.D. Eaton's co-authors include Kimberly Bowyer, Rajesh Chopra, Tiziano Barbui, Bronwen E. Shaw, H. G. Prentice, Massimo Iacobelli, Christoph Salat, Peter Neumeister, Mike Potter and Guido Finazzi and has published in prestigious journals such as British Journal of Haematology, Gene Therapy and British Journal of Urology.

In The Last Decade

J.D. Eaton

7 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.D. Eaton United Kingdom	6	196	92	90	75	70	7	351
Mary Beauchamp United States	8	117 0.6×	41 0.4×	46 0.5×	61 0.8×	18 0.3×	10	336
Gabriele Prange‐Krex Germany	6	270 1.4×	52 0.6×	51 0.6×	60 0.8×	32 0.5×	10	346
Sale Ge United States	10	183 0.9×	60 0.7×	38 0.4×	72 1.0×	27 0.4×	19	338
Ender Soydan Türkiye	8	181 0.9×	140 1.5×	121 1.3×	83 1.1×	12 0.2×	26	399
LT Goodnough United States	9	265 1.4×	62 0.7×	21 0.2×	95 1.3×	28 0.4×	10	394
Muthalagu Ramanathan United States	11	243 1.2×	103 1.1×	66 0.7×	102 1.4×	20 0.3×	53	390
Woo-Kun Kim South Korea	11	201 1.0×	146 1.6×	40 0.4×	38 0.5×	14 0.2×	14	340
Marc Schwartz United States	9	190 1.0×	72 0.8×	137 1.5×	20 0.3×	55 0.8×	26	412
Jody Folloder United States	9	310 1.6×	121 1.3×	25 0.3×	162 2.2×	26 0.4×	10	450
SJ Forman United States	8	413 2.1×	116 1.3×	57 0.6×	100 1.3×	30 0.4×	8	517

Countries citing papers authored by J.D. Eaton

Since Specialization

Citations

This map shows the geographic impact of J.D. Eaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.D. Eaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.D. Eaton more than expected).

Fields of papers citing papers by J.D. Eaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.D. Eaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.D. Eaton. The network helps show where J.D. Eaton may publish in the future.

Co-authorship network of co-authors of J.D. Eaton

This figure shows the co-authorship network connecting the top 25 collaborators of J.D. Eaton. A scholar is included among the top collaborators of J.D. Eaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.D. Eaton. J.D. Eaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Pandha, Hardev, Luke H. Stockwin, J.D. Eaton, et al.. (2003). Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies. Prostate Cancer and Prostatic Diseases. 6(1). 6–11. 22 indexed citations

2.

Eaton, J.D., et al.. (2003). Role of Plasminogen Activator Inhibitor-1 (PAI-1) Levels in the Diagnosis of BMT-associated Hepatic Veno-occlusive Disease and Monitoring of Subsequent Therapy with Defibrotide (DF). Hematology. 8(2). 91–95. 29 indexed citations

3.

Eaton, J.D., Matthew Perry, Steve Nicholson, et al.. (2002). Allogeneic whole‐cell vaccine: a phase I/II study in men with hormone‐refractory prostate cancer. British Journal of Urology. 89(1). 19–26. 56 indexed citations

4.

Eaton, J.D., Matthew Perry, Stephen Todryk, et al.. (2001). Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques. Gene Therapy. 8(7). 557–567. 15 indexed citations

5.

Dalgleish, AG, et al.. (2000). The immunotherapy of prostate cancer. Prostate Cancer and Prostatic Diseases. 3(4). 303–307. 1 indexed citations

6.

Chopra, Rajesh, J.D. Eaton, Anna Grassi, et al.. (2000). Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. British Journal of Haematology. 111(4). 1122–1129. 97 indexed citations

7.

Chopra, Rajesh, J.D. Eaton, Anna Grassi, et al.. (2000). Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use study. British Journal of Haematology. 111(4). 1122–1129. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact